A new study developed a mineralized DNA hydrogel that combines immune regulation with sustained bone regeneration. Using ...
In our bones, specialized cells called osteoblasts are responsible for building up bone substance. A team of researchers has now identified an enzyme that controls the activity of osteoblasts. An ...
A recent study identifies Neural EGFL-like 2 (NELL2), a secreted protein, as a key regulator of bone homeostasis, offering potential therapeutic applications for osteoporosis. NELL2 promotes ...
A new study developed a mineralized DNA hydrogel that combines immune regulation with sustained bone regeneration.
Researchers have shown that a naturally occurring peptide (small protein) holds promise as a new therapeutic for osteoporosis and other disorders that feature bone loss, with distinct advantages over ...
Around 40% of adults worldwide are affected by osteopenia: a loss of bone mineral density. This condition is extremely common particularly in postmenopausal women and elderly adults. It’s estimated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results